4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-057505
Chairman and CEO bought 3,582 shares at an average $1.68 ($6,017)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-09-21 | Purchase | +2,000 | $1.64 | $3,280 | 10,877,065 | D: show line 1 in the form |
| Niihara Yutaka Chairman and CEO | 2021-09-22 | Purchase | +1,582 | $1.73 | $2,737 | 10,878,647 | D: show line 2 in the form |
| Open-market purchases · 3,582 sh · avg $1.68 · $6,017 | |||||||
Loading xslF345X03/doc4.xml…